Skip to main content
. 2021 Feb 15;22(4):1918. doi: 10.3390/ijms22041918

Figure 1.

Figure 1

Immunolocalization of C-C chemokine ligand (CCL) 5 and C-C chemokine receptor (CCR) 1, CCR3 and CCR5 in human breast carcinoma tissues. (A,B) Representative images of the immunoreactivity for CCL5 in the stroma cells. (CH) Immunoreactivity for CCR1 (C,D), CCR3 (E,F) and CCR5 (G,H) was detected in the cytoplasm of breast carcinoma cells. (A,C,E,G) Positive cases and (B,D,F,H) negative cases. Bar = 100 μm, respectively.